Heart Failure, Systolic
124
16
22
50
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.9%
11 terminated out of 124 trials
82.0%
-4.5% vs benchmark
15%
18 trials in Phase 3/4
14%
7 of 50 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 50 completed trials
Clinical Trials (124)
Pilot Study Lp299v Supplementation in Chronic Heart Failure
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
A Study of LY3971297 in Participants With Heart Failure
Paced Heart Rate Acceleration for Cardiac Conditioning
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Effects of CRT Optimization as Assessed by Cardiac MR
Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany
Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)
Digital Remote Home Monitoring for Heart Failure
Cardiac Performance During Steep Trendelenburg Position in Patients Undergoing Robotic Surgery Surgery.
Predicting Heart Failure Outcomes With Biomarkers and Imaging
Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status
Physiological Effects of Lactate in Individuals With Chronic Heart Failure
Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
CardiAMP™ Cell Therapy for Heart Failure Trial
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
Hemodynamic-GUIDEd Management of Heart Failure
Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2